LAURA RAYKOWSKI: Open Payments
NPI 1407924566 · MONTESANO, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 29 payments from 11 companies in 2025. Trend: 2023 $478 · 2024 $654 · 2025 $614
Food & beverage: $614
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $158 |
| Alkermes, Inc. | 5 | $106 |
| Lundbeck LLC | 4 | $103 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Novo Nordisk Inc | 2 | $40 |
| ABBVIE INC. | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 2 | $31 |
| Exact Sciences Corporation | 1 | $20 |
| Viatris Specialty LLC | 1 | $18 |
| PFIZER INC. | 1 | $15 |
Products named: REXULTI, LYBALVI, AIRSUPRA, BREZTRI, Ozempic, VRAYLAR, GVOKE HYPOPEN, ARISTADA.
Industry payments across WA — which companies pay providers there.
